5-Methylheptanamide | 143826-97-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 5-Methylheptanamide
• CAS: 143826-97-5
• 化学式: C₈H₁₇NO
• mdl: MFCD19210589
• 分子量: 143.23
• InChiKey: PVDIWSSUJZTYJS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  43.1
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] PANTETHENOYLCYSTEINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE PANTÉTHÉNOYLCYSTÉINE ET LEURS UTILISATIONS
  申请人：COMET THERAPEUTICS INC

  公开号：WO2020198573A1

  公开（公告）日：2020-10-01

  The present disclosure relates to compounds of Formula (I) or (II): (Formulae (I), (II)), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.

  本公开涉及式(I)或(II)的化合物：(式(I)，(II))，以及其药用可接受的盐或溶剂化合物。本公开还涉及包含这些化合物的药物组合物，以及这些化合物和药物组合物的治疗和诊断用途。
• NOVEL 5-SUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP3022198B1

  公开（公告）日：2019-09-11
• ORAL DRUG DELIVERY DEVICE AND METHODS OF USING THE SAME
  申请人：UNIVERSITY OF IOWA RESEARCH FOUNDATION

  公开号：US20160367442A1

  公开（公告）日：2016-12-22

  A device to deliver drugs via transmucosal absorption in the oral cavity and methods of administering same. The device of the present invention includes a drug-releasing element, where the drug-releasing element includes at least one drug and where the drug-releasing element is capable of delivering at least one drug to the oral cavity, and an external securing element.
• [EN] ORAL DRUG DELIVERY DEVICE AND METHODS OF USING SAME<br/>[FR] DISPOSITIF DE DISTRIBUTION DE MÉDICAMENT PAR VOIE ORALE ET PROCÉDÉS D'UTILISATION CORRESPONDANTS
  申请人：UNIV IOWA RES FOUND

  公开号：WO2014210285A9

  公开（公告）日：2015-03-05

  [EN] A device to deliver drugs via transmucosal absorption in the oral cavity and methods of administering same. The device of the present invention includes a drug-releasing element, where the drug-releasing element includes at least one drug and where the drug-releasing element is capable of delivering at least one drug to the oral cavity, and an external securing element.
  [FR] L'invention concerne un dispositif pour administrer des médicaments par l'intermédiaire d'une absorption transmucosale, dans la cavité orale et des procédés d'administration associés. Le dispositif de la présente invention comprend un élément de libération de médicament, cet élément de libération de médicament comprenant au moins un médicament et permettant de délivrer au moins un médicament à la cavité buccale, et un élément de fixation externe.